Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Chinese Patent Office
QuintilesIMS
Baxter
Boehringer Ingelheim
Johnson and Johnson
McKinsey
Teva
Accenture
Queensland Health

Generated: February 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,579,855

« Back to Dashboard

Summary for Patent: 4,579,855
Title: Melfloquin hydrochloride
Abstract:Mefloquin hydrochloride in the form of modification E as characterized by IR spectrum and X-ray diffraction pattern, as well as a process for the preparation thereof by treating mefloquin hydrochloride, comprising at least partially another modification, that is, mefloquin hydrochloride which is not pure mefloquin hydrochloride in the form of modification E, with methanol and/or ethanol, in the presence of less than 30 volume/percent of water.
Inventor(s): Bomches; Helmut (Aesch, CH), Hardegger; Bruno (Riehen, CH)
Assignee: Hoffmann-La Roche Inc. (Nutley, NJ)
Application Number:06/655,813
Patent Claim Types:
see list of patent claims
Compound; Composition; Use;

Drugs Protected by US Patent 4,579,855

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,579,855

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Switzerland5459/83Oct 07, 1983

International Patents Family Members for US Patent 4,579,855

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 55387 ➤ Try a Free Trial
Bulgaria 60836 ➤ Try a Free Trial
Germany 3482926 ➤ Try a Free Trial
European Patent Office 0137375 ➤ Try a Free Trial
Japan H0255432 ➤ Try a Free Trial
Japan S60105675 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
QuintilesIMS
Federal Trade Commission
AstraZeneca
Deloitte
Teva
Baxter
Dow
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot